NSW Health & Medical Research | COVID-19 Vaccine Acceleration Research Grants

NSW Health invites applications for the NSW COVID-19 Vaccine Acceleration Research Grants Program.

Funding of up to $1 million per project for a period of up to 24 months is available from the Office for Health and Medical Research.

Applications for this grant closed at midday on 22 August 2022.

A peer review period of all applications will take place during August and September with funded applications to be announced during October 2022.

The NSW COVID-19 Vaccine Acceleration Research Grants Program has been designed to:

Specifically support research projects at Technology Readiness Levels 3B-6 (see Appendix A of the Guidelines below) that can rapidly undertake preclinical or early phase clinical studies to develop next-generation COVID-19 vaccines
Support research projects that address an unmet need in current COVID-19 vaccines, including (but not limited to) improving:
- vaccine safety profile
- resistance to new and/or multiple variants of SARS-CoV-2
- vaccine efficacy
- responses in immunocompromised or other at-risk populations
- the longevity of immunity
Reduce the time from evidence generation to implementation, through rapid planning, conduct and reporting of research that will make good progress towards commercialisation and translation into clinical practice and policy
Fund collaboration, leadership and capacity-building in the NSW vaccine research environment
Bridge a funding gap which may halt the progress of next-generation COVID-19 vaccine research and development in NSW, and
Support research that will add value to existing or planned initiatives, within the current Australian and international research landscape.

COVID-19 Vaccine Acceleration Research Program Guidelines

PDF - 1 MB

Download COVID-19 Vaccine Acceleration Research Program Guidelines

Updated 3 years ago

COVID-19 Vaccine Acceleration Research Grants